Toward multiomics-based next-generation diagnostics for precision medicine

References

• 1 Hood L, Flores M. A personal view on systems medicine and the emergence of proactive P4 medicine: predictive, preventive, personalized and participatory. N. Biotechnol. 29(6), 613–624 (2012).
  Medline CASGoogle Scholar
• 2 Lindor NM, Thibodeau SN, Burke W. Whole-genome sequencing in healthy people. Mayo Clin. Proc. 92(1), 159–172 (2017).
  MedlineGoogle Scholar
• 3 March R, Schott C. Personalized/precision medicine/personalised healthcare: the art of giving different names to the same thing? Per. Med. 14(6), 463–466 (2017).
  CASGoogle Scholar
• 4 Grainger D. The multi-omics revolution. J. Pers. Med. 81–86 (2016).
  Google Scholar
• 5 Schwarze K, Buchanan J, Taylor JC, Wordsworth S. Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature. Genet. Med. 20, 1122–1130 (2018).
  MedlineGoogle Scholar
• 6 Hogarth S, Javitt G, Melzer D. The current landscape for direct-to-consumer genetic testing: legal, ethical, and policy issues. Annu. Rev. Genomics Hum. Genet. 9(1), 161–182 (2008).
  Medline CASGoogle Scholar
• 7 Burton A. Are we ready for direct-to-consumer genetic testing? Lancet Neurol. 14(2), 138–139 (2015).
  MedlineGoogle Scholar
• 8 Ritchie MD, Holzinger ER, Li R, Pendergrass SA, Kim D. Methods of integrating data to uncover genotype–phenotype interactions. Nat. Rev. Genet. 16(2), 85–97 (2015).
  Medline CASGoogle Scholar
• 9 Rotroff DM, Motsinger-Reif AA. Embracing integrative multiomics approaches. Int. J. Genomics 2016, 1715985 (2016).
  MedlineGoogle Scholar
• 10 Cambiaghi A, Ferrario M, Masseroli M. Analysis of metabolomic data: tools, current strategies and future challenges for omics data integration. Brief. Bioinform. 18(3), 498–510 (2017).
  Medline CASGoogle Scholar
• 11 Arneson D, Shu L, Tsai B, Barrere-Cain R, Sun C, Yang X. Multidimensional integrative genomics approaches to dissecting cardiovascular disease. Front. Cardiovasc. Med. 4, 8 (2017).
  MedlineGoogle Scholar
• 12 Zhang W, Li F, Nie L. Integrating multiple ‘omics’ analysis for microbial biology: application and methodologies. Microbiology 156(2), 287–301 (2010).
  Medline CASGoogle Scholar
• 13 Manzoni C, Kia DA, Vandrovcova J et al. Genome, transcriptome and proteome: the rise of omics data and their integration in biomedical sciences. Brief. Bioinform. 19(2), 286–302 (2018).
  Medline CASGoogle Scholar
• 14 Alyass A, Turcotte M, Meyre D. From big data analysis to personalized medicine for all: challenges and opportunities. BMC Med. Genomics 8(1), 33 (2015).
  MedlineGoogle Scholar
• 15 Tebani A, Afonso C, Marret S, Bekri S. Omics-based strategies in precision medicine: toward a paradigm shift in inborn errors of metabolism investigations. Int. J. Mol. Sci. 17(9), pii: E1555 (2016).
  Google Scholar
• 16 Chrystoja CC, Diamandis EP. Whole genome sequencing as a diagnostic test: challenges and opportunities. Clin. Chem. 60(5), 724–733 (2014).
  Medline CASGoogle Scholar
• 17 Middleton A, Mendes Á, Benjamin CM, Howard HC. Direct-to-consumer genetic testing: where and how does genetic counseling fit? Per. Med. 14(3), 249–257 (2017).
  CASGoogle Scholar
• 18 Tsai EA, Shakbatyan R, Evans J et al. Bioinformatics workflow for clinical whole genome sequencing at partners healthcare personalized medicine. J. Pers. Med. 6(1), E12 (2016).
  MedlineGoogle Scholar
• 19 Jain M, Koren S, Miga KH et al. Nanopore sequencing and assembly of a human genome with ultra-long reads. Nat. Biotechnol. 36(4), 338–345 (2018).
  Medline CASGoogle Scholar
• 20 Seo JS, Rhie A, Kim J et al. De novo assembly and phasing of a Korean human genome. Nature 538(7624), 243–247 (2016).
  Medline CASGoogle Scholar
• 21 Lu H, Giordano F, Ning Z. Oxford Nanopore MinION sequencing and genome assembly. Genomics, Proteomics Bioinforma. 14(5), 265–279 (2016).
  MedlineGoogle Scholar
• 22 Norris AL, Workman RE, Fan Y, Eshleman JR, Timp W. Nanopore sequencing detects structural variants in cancer. Cancer Biol. Ther. 17(3), 246–253 (2016).
  Medline CASGoogle Scholar
• 23 de Lannoy C, de Ridder D, Risse J. A sequencer coming of age: de novo genome assembly using MinION reads. F1000Research 6, 1083 (2017).
  MedlineGoogle Scholar
• 24 Kalia SS, Adelman K, Bale SJ et al. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. Genet. Med. 19(2), 249–255 (2017).
  MedlineGoogle Scholar
• 25 Goldfeder RL, Ashley EA. A precision metric for clinical genome sequencing. bioRxiv 051490 (2016).
  Google Scholar
• 26 Hoffman-Andrews L. The known unknown: the challenges of genetic variants of uncertain significance in clinical practice. J. Law Biosci. 4(3), 648–657 (2017).
  MedlineGoogle Scholar
• 27 Rehm HL, Bale SJ, Bayrak-Toydemir P et al. ACMG clinical laboratory standards for next-generation sequencing. Genet. Med. 15(9), 733–747 (2013).
  MedlineGoogle Scholar
• 28 Phillips AM. ‘Only a click away – DTC genetics for ancestry, health, love…and more: a view of the business and regulatory landscape’. Appl. Transl. Genomics. 8, 16–22 (2016).
  MedlineGoogle Scholar
• 29 Niemiec E, Howard HC. Ethical issues in consumer genome sequencing: use of consumers’ samples and data. Appl. Transl. Genomics 8, 23–30 (2016).
  MedlineGoogle Scholar
• 30 Marzuillo C, De Vito C, D'Andrea E, Rosso A, Villari P. Predictive genetic testing for complex diseases: a public health perspective. QJM 107(2), 93–97 (2014).
  Medline CASGoogle Scholar
• 31 Ukraintseva S, Yashin A, Arbeev K et al. Puzzling role of genetic risk factors in human longevity: ‘risk alleles’ as pro-longevity variants. Biogerontology 17(1), 109–127 (2016).
  Medline CASGoogle Scholar
• 32 Badeaux AI, Shi Y. Emerging roles for chromatin as a signal integration and storage platform. Nat. Rev. Mol. Cell Biol. 14(4), 211–224 (2013).
  CASGoogle Scholar
• 33 Sadakierska-Chudy A, Kostrzewa RM, Filip M. A comprehensive view of the epigenetic landscape part I: DNA methylation, passive and active DNA demethylation pathways and histone variants. Neurotox. Res. 27(1), 84–97 (2015).
  Medline CASGoogle Scholar
• 34 Sadakierska-Chudy A, Filip M. A comprehensive view of the epigenetic landscape. Part II: histone post-translational modification, nucleosome level, and chromatin regulation by ncRNAs. Neurotox. Res. 27(2), 172–197 (2014).
  MedlineGoogle Scholar
• 35 Sandoval J, Peiró-Chova L, Pallardó FV, García-Giménez JL. Epigenetic biomarkers in laboratory diagnostics: emerging approaches and opportunities. Expert Rev. Mol. Diagn. 13(5), 457–471 (2013).
  Medline CASGoogle Scholar
• 36 Bell CG, Beck S. The epigenomic interface between genome and environment in common complex diseases. Brief. Funct. Genomics 9(5–6), 477–485 (2010).
  Medline CASGoogle Scholar
• 37 Heyn H, Méndez-González J, Esteller M. Epigenetic profiling joins personalized cancer medicine. Expert Rev. Mol. Diagn. 13(5), 473–479 (2013).
  Medline CASGoogle Scholar
• 38 Mensaert K, Denil S, Trooskens G, Van Criekinge W, Thas O, De Meyer T. Next-generation technologies and data analytical approaches for epigenomics. Environ. Mol. Mutagenesis 55, 155–170 (2014).
  Medline CASGoogle Scholar
• 39 Barski A, Cuddapah S, Cui K et al. High-resolution profiling of histone methylations in the human genome. Cell 129, 823–837 (2007).
  Medline CASGoogle Scholar
• 40 Yaragatti M, Basilico C, Dailey L. Identification of active transcriptional regulatory modules by the functional assay of DNA from nucleosome-free regions. Genome Res. 18(6), 930–938 (2008).
  Medline CASGoogle Scholar
• 41 Lister R, O'Malley RC, Tonti-Filippini J et al. Highly integrated single-base resolution maps of the epigenome in Arabidopsis. Cell 133(3), 523–536 (2008).
  Medline CASGoogle Scholar
• 42 Buenrostro JD, Wu B, Chang HY, Greenleaf WJ. ATAC-seq: a method for assaying chromatin accessibility genome-wide. Curr. Protoc. Mol. Biol. 109, 21.29.1–21.29.9 (2015).
  MedlineGoogle Scholar
• 43 Bock C, Halbritter F, Carmona FJ et al. Quantitative comparison of DNA methylation assays for biomarker development and clinical applications. Nat. Biotechnol. 34(7), 726–737 (2016).
  MedlineGoogle Scholar
• 44 Libertini E, Heath SC, Hamoudi RA et al. Information recovery from low coverage whole-genome bisulfite sequencing. Nat. Commun. 7, 11306 (2016).
  Medline CASGoogle Scholar
• 45 Wilson S, Fan L, Sahgal N, Qi J, Filipp FV. The histone demethylase KDM3A regulates the transcriptional program of the androgen receptor in prostate cancer cells. Oncotarget 8(18), 30328 (2017).
  MedlineGoogle Scholar
• 46 Tiffen J, Wilson S, Gallagher SJ, Hersey P, Filipp FV. Somatic copy number amplification and hyperactivating somatic mutations of EZH2 correlate With DNA methylation and drive epigenetic silencing of genes involved in tumor suppression and immune responses in melanoma. Neoplasia 18(2), 121–132 (2016).
  Medline CASGoogle Scholar
• 47 Byron SA, Van Keuren-Jensen KR, Engelthaler DM, Carpten JD, Craig DW. Translating RNA sequencing into clinical diagnostics: opportunities and challenges. Nat. Rev. Genet. 17(5), 257–271 (2016).
  Medline CASGoogle Scholar
• 48 Xu S. Transcriptome profiling in systems vascular medicine. Front. Pharmacol. 8, 563 (2017).
  MedlineGoogle Scholar
• 49 Sonawane AR, Platig J, Fagny M et al. Understanding tissue-specific gene regulation. Cell Rep. 21(4), 1077–1088 (2017).
  Medline CASGoogle Scholar
• 50 Vogel C, Marcotte EM. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat. Rev. Genet. 13(4), 227–232 (2012).
  Medline CASGoogle Scholar
• 51 Cesnik AJ, Shortreed MR, Sheynkman GM, Frey BL, Smith LM. Human proteomic variation revealed by combining RNA-seq proteogenomics and global post-translational modification (G-PTM) search strategy. J. Proteome Res. 15(3), 800–808 (2016).
  Medline CASGoogle Scholar
• 52 Li S, Todor A, Luo R. Blood transcriptomics and metabolomics for personalized medicine. Comput. Struct. Biotechnol. J. 14, 1–7 (2016).
  MedlineGoogle Scholar
• 53 Wrighton KH. Genetic testing: the diagnostic power of RNA-seq. Nat. Rev. Genet. 18, 392–393 (2017).
  Medline CASGoogle Scholar
• 54 Cummings BB, Marshall JL, Tukiainen T et al. Improving genetic diagnosis in Mendelian disease with transcriptome sequencing. Sci. Transl. Med. 9(386), pii: eaal5209 (2017).
  MedlineGoogle Scholar
• 55 James P. Protein identification in the post-genome era: the rapid rise of proteomics. Q. Rev. Biophys. 30(4), 279–331 (1997).
  Medline CASGoogle Scholar
• 56 Mann M, Jensen ON. Proteomic analysis of post-translational modifications. Nat. Biotechnol. 21(3), 255–261 (2003).
  Medline CASGoogle Scholar
• 57 Nice EC. From proteomics to personalized medicine: the road ahead. Expert Rev. Proteomics 13(4), 341–343 (2016).
  Medline CASGoogle Scholar
• 58 Aebersold R. A mass spectrometric journey into protein and proteome research. J. Am. Soc. Mass Spectrom. 14(7), 685–695 (2003).
  Medline CASGoogle Scholar
• 59 Kodadek T. Protein microarrays: prospects and problems. Chem. Biol. 8(2), 105–115 (2001).
  Medline CASGoogle Scholar
• 60 Duarte T, Spencer C. Personalized proteomics: the future of precision medicine. Proteome 4(4), 29 (2016).
  MedlineGoogle Scholar
• 61 Jin P, Lan J, Wang K, Baker MS, Huang C, Nice EC. Pathology, proteomics and the pathway to personalised medicine. Expert Rev. Proteomics 15(3), 231–243 (2018).
  Medline CASGoogle Scholar
• 62 Yu X, Petritis B, Duan H, Xu D, LaBaer J. Advances in cell-free protein array methods. Expert Rev. Proteomics 15(1), 1–11 (2018).
  MedlineGoogle Scholar
• 63 Velez G, Nathaniel Roybal C, Colgan D, Tsang SH, Bassuk AG, Mahajan VB. Personalized proteomics for the diagnosis and treatment of idiopathic inflammatory disease. JAMA Ophthalmol. 134(4), 444–448 (2016).
  MedlineGoogle Scholar
• 64 Sun YV, Hu YJ. Integrative analysis of multi-omics data for discovery and functional studies of complex human diseases. Adv. Genet. 93, 147–190 (2016).
  Medline CASGoogle Scholar
• 65 Beger RD, Dunn W, Schmidt MA et al. Metabolomics enables precision medicine: ‘a white paper, community perspective’. Metabolomics 12(10), 149 (2016).
  MedlineGoogle Scholar
• 66 Wandro S, Carmody L, Gallagher T, Lipuma JJ, Whiteson K. Making it last: storage time and temperature have differential impacts on metabolite profiles of airway samples from cystic fibrosis patients. mSystems 2(6), e00100-17 (2017).
  MedlineGoogle Scholar
• 67 Alonso A, Marsal S, Julià A. Analytical methods in untargeted metabolomics: state of the art in 2015. Front. Bioeng. Biotechnol. 3, 23 (2015).
  MedlineGoogle Scholar
• 68 Metabolon (2017). www.metabolon.com/.
  Google Scholar
• 69 Yeung PK. Metabolomics and biomarkers for drug discovery. Metabolites 8(1), 11 (2018).
  Google Scholar
• 70 Coene KLM, Kluijtmans LAJ, van der Heeft E et al. Next-generation metabolic screening: targeted and untargeted metabolomics for the diagnosis of inborn errors of metabolism in individual patients. J. Inherit. Metab. Dis. 41(3), 337–353 (2018).
  Medline CASGoogle Scholar
• 71 Puchades-Carrasco L, Pineda-Lucena A. Metabolomics applications in precision medicine: an oncological perspective. Curr. Top. Med. Chem. 17(24), 2740–2751 (2017).
  Medline CASGoogle Scholar
• 72 Kuntz TM, Gilbert JA. Introducing the microbiome into precision medicine. Trends Pharmacol. Sci. 38(1), 81–91 (2017).
  Medline CASGoogle Scholar
• 73 Petrosino JF. The microbiome in precision medicine: the way forward. Genome Med. 10(1), 12 (2018).
  MedlineGoogle Scholar
• 74 Scarpellini E, Ianiro G, Attili F, Bassanelli C, De Santis A, Gasbarrini A. The human gut microbiota and virome: potential therapeutic implications. Dig. Liver Dis. 47(12), 1007–1012 (2015).
  MedlineGoogle Scholar
• 75 Maruvada P, Leone V, Kaplan LM, Chang EB. The human microbiome and obesity: moving beyond associations. Cell Host Microbe. 22(5), 589–599 (2017).
  Medline CASGoogle Scholar
• 76 Jovel J, Patterson J, Wang W et al. Characterization of the gut microbiome using 16S or shotgun metagenomics. Front. Microbiol. 7, 459 (2016).
  MedlineGoogle Scholar
• 77 Sekse C, Holst-Jensen A, Dobrindt U et al. High-throughput sequencing for detection of foodborne pathogens. Front. Microbiol. 8, 2029 (2017).
  MedlineGoogle Scholar
• 78 Daniels L, Budding AE, de Korte N et al. Fecal microbiome analysis as a diagnostic test for diverticulitis. Eur. J. Clin. Microbiol. Infect. Dis. 33(11), 1927–1936 (2014).
  Medline CASGoogle Scholar
• 79 The Medical Futurist (2019). https://medicalfuturist.com/.
  Google Scholar
• 80 Zhang C, Cleveland K, Schnoll-Sussman F et al. Identification of low abundance microbiome in clinical samples using whole genome sequencing. Genome Biol. 16(1), 265 (2015).
  Medline CASGoogle Scholar
• 81 Poussin C, Sierro N, Boué S et al. Interrogating the microbiome: experimental and computational considerations in support of study reproducibility. Drug Discov. Today 23(9), 1644–1657 (2018).
  Medline CASGoogle Scholar
• 82 Feldbauer R, Schulz F, Horn M, Rattei T. Prediction of microbial phenotypes based on comparative genomics. BMC Bioinformatics 16(14), S1 (2015).
  MedlineGoogle Scholar
• 83 Samb-Ba B, Mazenot C, Gassama-Sow A et al. 1DUMMY MALDI-TOF identification of the human gut microbiome in people with and without diarrhea in Senegal. PLoS ONE 9(5), e87419 (2014).
  MedlineGoogle Scholar
• 84 Gopalakrishnan V, Spencer CN, Nezi L et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science 359(6371), 97–103 (2018).
  Medline CASGoogle Scholar
• 85 Matson V, Fessler J, Bao R et al. The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science 359(6371), 104–108 (2018).
  Medline CASGoogle Scholar
• 86 Routy B, Le Chatelier E, Derosa L et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science 359(6371), 91–97 (2018).
  Medline CASGoogle Scholar
• 87 Teixeira AP, Dias JML, Carinhas N et al. Cell functional enviromics: unravelling the function of environmental factors. BMC Syst. Biol. 5, 92 (2011).
  MedlineGoogle Scholar
• 88 Vineis P, Chadeau-Hyam M, Gmuender H et al. The exposome in practice: design of the EXPOsOMICS project. Int. J. Hyg. Environ. Health. 220, 142–151 (2016).
  MedlineGoogle Scholar
• 89 Obama White House. https://obamawhitehouse.archives.gov/precision-medicine/.
  Google Scholar
• 90 Biden's Cancer Initiative (2018). https://bidencancer.org/.
  Google Scholar
• 91 Institute for Systems Biology (2019). https://systemsbiology.org/research/100k-wellness-project/.
  Google Scholar
• 92 Chen R, Mias GI, Li-Pook-Than J et al. Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell 148(6), 1293–1307 (2012).
  Medline CASGoogle Scholar
• 93 Huang S, Chaudhary K, Garmire LX. More is better: recent progress in multi-omics data integration methods. Front. Genet. 8, 84 (2017).
  Medline CASGoogle Scholar
• 94 Shen R, Mo Q, Schultz N et al. Integrative subtype discovery in glioblastoma using iCluster. PLoS ONE 7(4), e35236 (2012).
  Medline CASGoogle Scholar
• 95 Lock EF, Dunson DB. Bayesian consensus clustering. Bioinformatics 29(20), 2610–2616 (2013).
  Medline CASGoogle Scholar
• 96 Bonnet E, Calzone L, Michoel T. Integrative multi-omics module network inference with lemon-tree. PLoS Comput. Biol. 11(2), e1003983 (2015).
  MedlineGoogle Scholar
• 97 Louhimo R, Hautaniemi S. CNAmet: an R package for integrating copy number, methylation and expression data. Bioinformatics 27(6), 887–888 (2011).
  Medline CASGoogle Scholar
• 98 Kim D, Li R, Dudek SM, Ritchie MD. ATHENA: identifying interactions between different levels of genomic data associated with cancer clinical outcomes using grammatical evolution neural network. BioData Min. 6(1), 23 (2013).
  MedlineGoogle Scholar
• 99 Lanckriet GRG, De Bie T, Cristianini N, Jordan MI, Noble S. A statistical framework for genomic data fusion. Bioinformatics 20(16), 2626–2635 (2004).
  Medline CASGoogle Scholar
• 100 Ovaska K, Laakso M, Haapa-Paananen S et al. Large-scale data integration framework provides a comprehensive view on glioblastoma multiforme. Genome Med. 2(9), 65 (2010).
  MedlineGoogle Scholar
• 101 O'Driscoll A, Daugelaite J, Sleator RD. ‘Big data, Hadoop and cloud computing in genomics. J. Biomed. Inform. 46(5), 774–781 (2013).
  MedlineGoogle Scholar
• 102 Amazon Web Services (2019). https://aws.amazon.com/.
  Google Scholar
• 103 Dai L, Gao X, Guo Y, Xiao J, Zhang Z. Bioinformatics clouds for big data manipulation. Biol. Direct. 7, 43 (2012).
  MedlineGoogle Scholar
• 104 ELIXIR (2017). www.elixir-europe.org/.
  Google Scholar
• 105 Galaxy (2019). usegalaxy.org/.
  Google Scholar
• 106 Hiltemann S, Mei H, de Hollander M et al. CGtag: complete genomics toolkit and annotation in a cloud-based Galaxy. Gigascience 3(1), 1 (2014).
  MedlineGoogle Scholar
• 107 Zhao K, Lu ZX, Park JW, Zhou Q, Xing Y. GLiMMPS: obust statistical model for regulatory variation of alternative splicing using RNA-seq data. Genome Biol. 14(7), R74 (2013).
  MedlineGoogle Scholar
• 108 Nguyen QH, Pervolarakis N, Blake K et al. Profiling human breast epithelial cells using single cell RNA sequencing identifies cell diversity. Nat. Commun. 9(1), 2028 (2018).
  MedlineGoogle Scholar
• 109 Mardis ER. The 1000 genome, the 100,000 analysis? Genome Med. 2(11), 84 (2010).
  MedlineGoogle Scholar